1. FDA Committee Votes 6-6 on Durect's Non-Opioid Pain Drug — Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 — Novo Nordisk's Ozempic wins FDA label boost with CV indication — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

POA

Discussion in 'Mission Pharmacal' started by anonymous, Jan 7, 2016 at 5:41 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Who's looking forward to the upcoming POA? It promises to be just as pointless and a complete waste of time as the last one.
     

  2. anonymous

    anonymous Guest

    i love how they are flying everyone in for a day and half worth of meetings. But they just need you to know that the company so doing great.
     
  3. anonymous

    anonymous Guest

    can't wait to see who gets shitfaced and makes a fool of themselves. last time my roommate was puking all night and almost missed her flight the next day. good times.
     
  4. anonymous

    anonymous Guest

     
  5. anonymous

    anonymous Guest

    I agree. We could have covered the material on a conference call